Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Iwona Dębosz-Suwińska"'
Publikováno v:
Nowotwory. Journal of Oncology. 72:372-377
Publikováno v:
Nowotwory. Journal of Oncology. 72:161-166
Autor:
Agata Małgorzata Wilk, Emilia Kozłowska, Damian Borys, Andrea D’Amico, Krzysztof Fujarewicz, Izabela Gorczewska, Iwona Dębosz-Suwińska, Rafał Suwiński, Jarosław Śmieja, Andrzej Swierniak
BackgroundNon-small cell lung cancer (NSCLC) is the most common type of lung cancer, and the median overall survival is approximately 2-3 years among patients with stage III disease. Furthermore, it is one of the deadliest types of cancer globally du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e94b853cb1b31537826fd4282014d0e5
https://doi.org/10.1101/2023.01.31.23285230
https://doi.org/10.1101/2023.01.31.23285230
Autor:
Agnieszka Namysl-Kaletka, Jerzy Wydmanski, Iwona Debosz-Suwinska, Malgorzata Kaszuba, Dorota Gabrys, Agata Roch-Zniszczol, Daria Handkiewicz-Junak
Publikováno v:
Current Oncology, Vol 31, Iss 7, Pp 4123-4132 (2024)
Insulinoma is the most common functional neuroendocrine tumor of the pancreas, with the main clinical symptom being hypoglycemia. The standard treatment is surgery, but some patients are not eligible for surgery, while in those operated on, the risk
Externí odkaz:
https://doaj.org/article/34b7987ff91c48cb931206bc822bba5e
Publikováno v:
Recent Challenges in Intelligent Information and Database Systems ISBN: 9789811982330
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::749e5c910d27ac3152738d15dbda136a
https://doi.org/10.1007/978-981-19-8234-7_18
https://doi.org/10.1007/978-981-19-8234-7_18
Autor:
Marcin Rajczykowski, Katarzyna Galwas-Kliber, Ewa Stobiecka, Iwona Dębosz-Suwińska, Adam Idasiak, Jolanta Mrochem-Kwarciak, Rafał Suwiński, Marcin Zeman
Publikováno v:
Neoplasma. 68(3)
We investigated the tumor regression grading (TRG) as a prognostic marker for disease-free survival (DFS) in patients with advanced rectal cancer treated within phase III randomized study (ClinicalTrials.gov Identifier: NCT01814969). The study is sti